rss
Br J Ophthalmol 2008;92:678-682 doi:10.1136/bjo.2007.124768
  • Laboratory science
    • Original Article

Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis

  1. C Ferrer1,
  2. A Rodríguez1,
  3. J L Abad1,
  4. J Fernandez1,
  5. J L Alió1,2
  1. 1
    Department of Molecular Biology, VISSUM, Institute of Ophthalmology of Alicante, Alicante, Spain
  2. 2
    Division of Ophthalmology, Faculty of Medicine, University of Miguel Hernández, Alicante, Spain
  1. Dr C Ferrer, VISSUM, Instituto Oftalmológico de Alicante, Avenida de Denia s/n, 03016 Alicante, Spain; cferrer{at}vissum.com
  • Accepted 25 November 2007
  • Published Online First 22 January 2008

Abstract

Aim: To evaluate the efficacy of intravitreal 1.5% levofloxacin versus combined treatment with vancomycin and ceftazidime in an experimental model of bacterial endophthalmitis.

Methods: The right eye of 75 New Zealand White rabbits was inoculated in the vitreous cavity with strains of Staphylococcus epidermidis, Staphylococcus aureus or Pseudomonas aeruginosa. The study evaluated treatment with 1.5% levofloxacin compared with 1% vancomycin plus 2.2% ceftazidime, and a control group. At 24 h after treatment, 100 μl vitreous and aqueous humor were harvested, and the number of colony-forming units (CFU) per ml was determined. The microbiological status of the vitreous and aqueous humor samples was tested at day 2, 3, 5 and 8. The Peyman classification was used to assess the severity of endophthalmitis.

Results: For the S epidermidis endophthalmitis model, levofloxacin treatment produced an approximately 3 log decrease in CFU/ml of vitreous relative to that in untreated eyes (p = 0.023), whereas vancomycin plus ceftazidime produced a 5 log reduction in CFU/ml (p = 0.023). However, in the S aureus model, levofloxacin treatment produced an approximately 4 log reduction in CFU/ml, whereas vancomycin plus ceftazidime produced an approximately 2 log reduction in CFU/ml relative to that of the control (p = 0.018 and p = 0.019, respectively). Treatment of P aeruginosa-infected rabbit eyes with levofloxacin produced a 5 log reduction in CFU/ml of vitreous, whereas vancomycin plus ceftazidime produced an approximately 3–4 log reduction in CFU/ml relative to that of the control (p = 0.001). However, there was no significant difference between levofloxacin and vancomycin plus ceftazidime on comparing the reduction of CFU/ml of vitreous for any of the bacterial strains studied.

Conclusions: Levofloxacin appears to be effective in treating experimental endophthalmitis in the rabbit model. Further studies, especially on the toxicity of intravitreal levofloxacin, are required before a clinical role for the drug in postoperative therapy can be determined.

Footnotes

  • Funding: This work was supported by a grant from Santen OY, Finland and Vissum Corporation, Instituto Oftalmológico de Alicante, Alicante, Spain.

  • Competing interests: VISSUM has received funds for research from Santen OY, Finland.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. bjo.2007.124768v1
    2. 92/5/678 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.